Angel Matthew bought TPST
March 24, 2026 · Form 4 insider transaction
Angel Matthew bought 231,482 shares of Tempest Therapeutics, Inc. at $2.16 per share, a transaction worth $500.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
231,482
Price
$2.16
Total value
$500.0K
InsiderAngel Matthew
RoleOfficer, Director, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 24, 2026
Filing dateMarch 25, 2026
Shares owned after231,482
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The shares are held by Factor Bioscience Inc. ("Factor"). The Reporting Peron is the chief executive officer and chairman of the board of directors of Factor and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.